Aberdeen Group
BDSX icon

Aberdeen Group’s Biodesix BDSX Stock Holding History

Aberdeen Group’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.76M Sell
388,639
-69,799
-15% -$1.03M 0.01% 625
2026
Q1 		$6.65M Buy
458,438
+196,013
+75% +$2.43M 0.01% 659
2025
Q4 		$1.78M Buy
+262,425
New +$1.93M ﹤0.01% 788

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Aberdeen Group's BDSX Position: Q2 2026 in Review

Aberdeen Group reduced its Biodesix (BDSX) stake by 15% in Q2 2026, selling an estimated $1.03M and leaving 388,639 shares worth $8.76M. The position accounts for 0.01% of the portfolio, ranked #625.

Aberdeen Group first reported a position in BDSX in Q4 2025 and has held it in 3 quarters since. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Aberdeen Group held 388,639 shares of Biodesix worth $8.76M as of Q2 2026.
  • Aberdeen Group sold 69,799 Biodesix shares in Q2 2026, an estimated $1.03M.
  • Biodesix made up 0.01% of Aberdeen Group's portfolio in Q2 2026, its #625 holding.
  • Aberdeen Group first reported a position in Biodesix in Q4 2025 and has held it in 3 quarters since.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.